Search results
InnoCare Pharma concludes subject enrolment Phase II psoriasis trial
Clinical Trials Arena via Yahoo Finance· 10 hours agoInnoCare Pharma has announced the completion of subject enrolment in the Phase II clinical trial of...
Moleculin begins NIH-funded Phase II glioblastoma treatment trial
Clinical Trials Arena via Yahoo Finance· 8 hours agoMoleculin Biotech has announced the initiation of an investigator-initiated Phase II NU 21C06...
Star USC scientist faces scrutiny — retracted papers and a paused drug trial
LA Times via AOL· 8 hours agoUSC's Berislav Zlokovic has faced questions about the integrity of his research. Since a...
NeuroSense taps PhaseV’s ML tech for Phase III ALS trial analysis
Clinical Trials Arena via Yahoo Finance· 1 day agoPhaseV will analyse NeuroSense’s Phase II ALS trial data, and results from these will inform Phase...
CEQ’s Empty Promises On Permit Streamlining
Forbes· 13 hours agoThe Council on Environmental Quality (CEQ) recently finalized its Phase II rule under the National Environmental Policy Act (NEPA), which it is touting...
Ryvu Therapeutics First Quarter 2024 Financial Results and Corporate Update
CBS 47 Fresno· 2 days agoThis cash position, and other secured funding sources, provide a runway through Q1 2026. In Q1 2024, Ryvu announced the initiation of two Phase II studies ...
Earnings call: Protalix BioTherapeutics Q1 2024 financial results By Investing.com
Investing.com· 6 days agoThe company announced the expansion of their Phase I study for PRX-115, a recombinant uricase...
Uniquity Bio launches to focus on immunology and inflammation
Pharmaceutical Technology via Yahoo Finance· 8 hours agoThe development comes after Blackstone obtained the US Food and Drug Administration clearance for...
Q1 2024 Panbela Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 hours agoThis study, funded by the NCI and conducted by the Southwest Oncology Group, known as SWOG, successfully passed the planned futility analysis. Moving on to our Phase
Pipeline Moves: Phase III completion for Corcept’s relaorilant
Clinical Trials Arena via Yahoo Finance· 3 days agoMeanwhile, Regeneron has completed a Phase II trial of its candidate mibavademab in lipodystrophy...